These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33962356)

  • 1. The Danish metastatic melanoma database (DAMMED): A nation-wide platform for quality assurance and research in real-world data on medical therapy in Danish melanoma patients.
    Ellebaek E; Svane IM; Schmidt H; Haslund CA; Donia M; Hoejberg L; Ruhlmann C; Guldbrandt LM; Køhler UH; Bastholt L
    Cancer Epidemiol; 2021 Aug; 73():101943. PubMed ID: 33962356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
    Gershenwald JE; Scolyer RA; Hess KR; Sondak VK; Long GV; Ross MI; Lazar AJ; Faries MB; Kirkwood JM; McArthur GA; Haydu LE; Eggermont AMM; Flaherty KT; Balch CM; Thompson JF;
    CA Cancer J Clin; 2017 Nov; 67(6):472-492. PubMed ID: 29028110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The real-world impact of modern treatments on the survival of patients with metastatic melanoma.
    Donia M; Ellebaek E; Øllegaard TH; Duval L; Aaby JB; Hoejberg L; Køhler UH; Schmidt H; Bastholt L; Svane IM
    Eur J Cancer; 2019 Feb; 108():25-32. PubMed ID: 30605822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of American Joint Committee on Cancer 8th edition classification on staging and survival of patients with melanoma.
    Kanaki T; Stang A; Gutzmer R; Zimmer L; Chorti E; Sucker A; Ugurel S; Hadaschik E; Gräger NS; Satzger I; Schadendorf D; Livingstone E
    Eur J Cancer; 2019 Sep; 119():18-29. PubMed ID: 31401470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The majority of patients with metastatic melanoma are not represented in pivotal phase III immunotherapy trials.
    Donia M; Kimper-Karl ML; Høyer KL; Bastholt L; Schmidt H; Svane IM
    Eur J Cancer; 2017 Mar; 74():89-95. PubMed ID: 28335891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Population-Based Comparison of the AJCC 7th and AJCC 8th Editions for Patients Diagnosed with Stage III Cutaneous Malignant Melanoma in Sweden.
    Isaksson K; Katsarelias D; Mikiver R; Carneiro A; Ny L; Olofsson Bagge R
    Ann Surg Oncol; 2019 Sep; 26(9):2839-2845. PubMed ID: 31111349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life and mental health in real-world patients with resected stage III/IV melanoma receiving adjuvant immunotherapy.
    Pedersen S; Holmstroem RB; von Heymann A; Tolstrup LK; Madsen K; Petersen MA; Haslund CA; Ruhlmann CH; Schmidt H; Johansen C; Svane IM; Ellebaek E
    Acta Oncol; 2023 Jan; 62(1):62-69. PubMed ID: 36645166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dutch Melanoma Treatment Registry: Quality assurance in the care of patients with metastatic melanoma in the Netherlands.
    Jochems A; Schouwenburg MG; Leeneman B; Franken MG; van den Eertwegh AJ; Haanen JB; Gelderblom H; Uyl-de Groot CA; Aarts MJ; van den Berkmortel FW; Blokx WA; Cardous-Ubbink MC; Groenewegen G; de Groot JW; Hospers GA; Kapiteijn E; Koornstra RH; Kruit WH; Louwman MW; Piersma D; van Rijn RS; Ten Tije AJ; Vreugdenhil G; Wouters MW; van der Hoeven JJ
    Eur J Cancer; 2017 Feb; 72():156-165. PubMed ID: 28030784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanoma of the Skin in the Danish Cancer Registry and the Danish Melanoma Database: A Validation Study.
    Pedersen SA; Schmidt SAJ; Klausen S; Pottegård A; Friis S; Hölmich LR; Gaist D
    Epidemiology; 2018 May; 29(3):442-447. PubMed ID: 29337844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial.
    Eggermont AMM; Blank CU; Mandalà M; Long GV; Atkinson VG; Dalle S; Haydon AM; Meshcheryakov A; Khattak A; Carlino MS; Sandhu S; Larkin J; Puig S; Ascierto PA; Rutkowski P; Schadendorf D; Koornstra R; Hernandez-Aya L; Di Giacomo AM; van den Eertwegh AJM; Grob JJ; Gutzmer R; Jamal R; Lorigan PC; van Akkooi ACJ; Krepler C; Ibrahim N; Marreaud S; Kicinski M; Suciu S; Robert C;
    Lancet Oncol; 2021 May; 22(5):643-654. PubMed ID: 33857412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved stratification of pT1 melanoma according to the 8th American Joint Committee on Cancer staging edition criteria: A Dutch population-based study.
    Verver D; Louwman WJ; Koljenović S; Verhoef C; Grünhagen DJ; van Akkooi ACJ
    Eur J Cancer; 2018 Mar; 92():100-107. PubMed ID: 29217356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant therapy of malignant melanoma and the role of sentinel node mapping.
    Eggermont AM
    Recent Results Cancer Res; 2000; 157():178-89. PubMed ID: 10857171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care.
    Keung EZ; Gershenwald JE
    Expert Rev Anticancer Ther; 2018 Aug; 18(8):775-784. PubMed ID: 29923435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial.
    Amaria RN; Prieto PA; Tetzlaff MT; Reuben A; Andrews MC; Ross MI; Glitza IC; Cormier J; Hwu WJ; Tawbi HA; Patel SP; Lee JE; Gershenwald JE; Spencer CN; Gopalakrishnan V; Bassett R; Simpson L; Mouton R; Hudgens CW; Zhao L; Zhu H; Cooper ZA; Wani K; Lazar A; Hwu P; Diab A; Wong MK; McQuade JL; Royal R; Lucci A; Burton EM; Reddy S; Sharma P; Allison J; Futreal PA; Woodman SE; Davies MA; Wargo JA
    Lancet Oncol; 2018 Feb; 19(2):181-193. PubMed ID: 29361468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose interleukin-2 and interferon as first-line immunotherapy for metastatic melanoma: long-term follow-up in a large unselected Danish patient cohort.
    Bastholt L; Svane IM; Bjerregaard JK; Herrstedt J; Hróbjartsson A; Schmidt H
    Eur J Cancer; 2019 Jul; 115():61-67. PubMed ID: 31108244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification of 3097 patients from the Japanese melanoma study database using the American joint committee on cancer eighth edition cancer staging system.
    Fujisawa Y; Yoshikawa S; Minagawa A; Takenouchi T; Yokota K; Uchi H; Noma N; Nakamura Y; Asai J; Kato J; Fujiwara S; Fukushima S; Uehara J; Hoashi T; Kaji T; Fujimura T; Namikawa K; Yoshioka M; Murata N; Ogata D; Matsuyama K; Hatta N; Shibayama Y; Fujiyama T; Ishikawa M; Yamada D; Kishi A; Nakamura Y; Shimiauchi T; Fujii K; Fujimoto M; Ihn H; Katoh N
    J Dermatol Sci; 2019 May; 94(2):284-289. PubMed ID: 31023613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External validation of the American Joint Committee on Cancer 8th edition melanoma staging system: who needs adjuvant treatment?
    Madu MF; Franke V; Van de Wiel BA; Klop WMC; Jóźwiak K; van Houdt WJ; Wouters MWJM; van Akkooi ACJ
    Melanoma Res; 2020 Apr; 30(2):185-192. PubMed ID: 31651715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in melanoma in the elderly in Denmark, 1980-2012.
    Hoejberg L; Gad D; Gyldenkerne N; Bastholt L;
    Acta Oncol; 2016; 55 Suppl 1():52-8. PubMed ID: 26785326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimates of stage-specific survival are altered by changes in the 2002 American Joint Committee on Cancer staging system for melanoma.
    Ben-Porat L; Panageas KS; Hanlon C; Patel A; Halpern A; Houghton AN; Coit D
    Cancer; 2006 Jan; 106(1):163-71. PubMed ID: 16331596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB-C, BRAF
    Long GV; Saw RPM; Lo S; Nieweg OE; Shannon KF; Gonzalez M; Guminski A; Lee JH; Lee H; Ferguson PM; Rawson RV; Wilmott JS; Thompson JF; Kefford RF; Ch'ng S; Stretch JR; Emmett L; Kapoor R; Rizos H; Spillane AJ; Scolyer RA; Menzies AM
    Lancet Oncol; 2019 Jul; 20(7):961-971. PubMed ID: 31171444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.